Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-30 · accession 0001209191-21-054096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-31 | 2021-08-30 | VIR | Napolitano Janet | Dir | M - OptEx | $41.64 | +1,435 | 4,809 | +43% | +$59.8K |
| D | 2021-08-31 | 2021-08-30 | VIR | Napolitano Janet | Dir | S - Sale+OE | $51.15 | -1,435 | 3,374 | -30% | -$73.4K |
| D | 2021-08-31 | 2021-08-30 | VIR | Napolitano Janet | Dir | M - OptEx | $0.00 | +1,435 | 31.6K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | M | A | 1,435 | $41.64 | 4,809 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-30 | S | D | 1,435 | $51.15 | 3,374 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-30 | M | A | 1,435 | $0.00 | 31,565 | D | $41.64 · — to 2030-08-28 | 1,435 Common Stock | (F2) 1/3 of the shares subject to the stock option vested and became exercisable on August 28, 2021, and the remaining shares vest in 24 equal monthly installments thereafter. |